Stay updated on NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial
Sign up to get notified when there's something new on the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page.

Latest updates to the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page
- Check5 days agoChange DetectedThe study page shows a newer revision tag, v3.5.3, indicating an updated version of the ClinicalTrials.gov entry. The prior revision, v3.5.2, has been replaced.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded “Schizophrenia” related topic links, including MedlinePlus Genetics.SummaryDifference0.2%

- Check20 days agoChange DetectedAdded a new page revision tag 'Revision: v3.5.2' and removed the older revision tag 'Revision: v3.5.0' along with the related topics listing.SummaryDifference0.2%

- Check27 days agoChange DetectedAdded related topics links for Schizophrenia and MedlinePlus Genetics to the page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page no longer lists the primary condition 'Schizophrenia' and related topics/MedlinePlus Genetics.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded Schizophrenia topic and MedlinePlus Genetics related topics, and updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page.